Meet our experts

Insights and expertise to empower your business

At QbD Group, we believe that expertise drives progress. Our thought leadership platform connects you with our leading professionals, who share their deep knowledge, innovative ideas, and actionable insights to address the challenges and opportunities in life sciences. This initiative offers valuable perspectives that empower your business to make informed decisions and stay ahead in a competitive market.
Circles-banner-short

Why is this initiative valuable for you?

Our thought leadership platform is designed with your needs in mind. By engaging with our thought leaders, you gain access to:

Cutting-edge insights

Stay informed about the latest trends, innovations, and solutions in life sciences.

Credible expertise

Trust in the knowledge and experience of industry leaders who understand your challenges.

Practical solutions

Get actionable advice to improve compliance, innovation, and operational efficiency.

Strategic advantage

Position your business to lead in your field with the help of reliable insights from QbD Group.

Meet our experts

Explore the professionals shaping the future of life sciences at QbD Group. Each expert brings unique expertise in areas such as regulatory science, pharmacovigilance, quality management, and more. Click on a leader below to learn more about their expertise and how they can support your goals.

Anne-Sophie Grell

Manager Regulatory Affairs – Medical Devices

Pieter Smits

Project Governance Lead

Jonathan Boel

Division Head Software Solutions & Services

Ward Neefs

Life Science Consultant

Jo Doucet

Division Head Qualification & Validation

Kirsten Van Garsse

Director Authorised Representative Services & Manager IVD – Regulatory Affairs

Peter Fry

Business Unit Manager, Regulatory Affairs Pharma & Country Manager UK

Explore our expert content

Scaling PV Governance in Europe: Maintaining Oversight as Organizations Grow
13 Feb 2026

Scaling PV Governance in Europe: Maintaining Oversight as...

Annex 1 Cleanrooms, Isolators and RABS: Designing for Aseptic Compliance
13 Feb 2026

Cleanrooms, Isolators and RABS: Meeting Annex 1...

Early Orphan Strategy: Regulatory and Commercial Considerations Across EU, US and UK
13 Feb 2026

Deciding Early on an Orphan Strategy: A Strategic Choice,...

Nitrosamine Impurities in Medicinal Products: Risks and Regulatory Insights - QbD Group
9 Feb 2026

Nitrosamine Impurities in Medicinal Products: Risks and...

vector-img
Case Study - Helping Abraca BioSystems to obtain ISO 13485 certification

Don't miss our industry updates

Circles_banner_short-1